Biorelevant Dissolution of Dipyridamole and Piroxicam Using an Automated UV/Vis Spectrophotometric and Potentiometric Dissolution Testing Platform
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Biorelevant Dissolution of Dipyridamole and Piroxicam Using an Automated UV/Vis Spectrophotometric and Potentiometric Dissolution Testing Platform. / Berthelsen, Ragna; Larsen, Susan Weng; Müllertz, Anette; Box, Karl; Østergaard, Jesper.
In: Dissolution Technologies, Vol. 30, No. 3, 2023, p. 144-153.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Biorelevant Dissolution of Dipyridamole and Piroxicam Using an Automated UV/Vis Spectrophotometric and Potentiometric Dissolution Testing Platform
AU - Berthelsen, Ragna
AU - Larsen, Susan Weng
AU - Müllertz, Anette
AU - Box, Karl
AU - Østergaard, Jesper
N1 - Publisher Copyright: © 2023, Dissolution Technologies Inc. All rights reserved.
PY - 2023
Y1 - 2023
N2 - The objective of this study was to investigate the implications of changing dissolution parameters, including pH ramp time, absence and presence of simulated intestinal fluid (SIF), and the addition of a partitioning phase, using an automated dissolution-testing platform. The molar absorption coefficients, pKa, and dissolution characteristics of dipyridamole and piroxicam were investigated in the UV/Vis spectrophotometric and potentiometric platform, inForm (Pion Inc). Dissolution of dipyridamole and piroxicam from 10-mg compacts (tablets) was studied at pH 2.0 and 6.5 in fasted-state SIF version 2 (v2) and in biphasic media using decanol as the partitioning phase. Transfer through the gastrointestinal tract was simulated by shifting pH from 2.0 to 6.5 during dissolution testing. Dipyridamole (pKa 6.0) dissolved rapidly at pH 2.0; however, changing the pH to 6.5 brought dipyridamole into a supersaturated state, from which it precipitated. Precipitation was slower in the presence of SIF, and higher dipyridamole concentrations were maintained in solution compared with simple buffer systems. In the biphasic dissolution assay, rapid distribution of dipyridamole into the lipophilic partitioning phase minimized drug precipitation. For piroxicam (pKa1 1.9; pKa2 5.3), the dissolution rate increased with increasing pH. The inclusion of SIF and introduction of a partition phase had limited influence on piroxicam dissolution. The automated platform facilitated efficient exploration of dissolution conditions. Tailoring of dissolution assays including pH gradients, SIF, and biphasic partitioning enabled detailed drug characterization, increased biorelevance, and possibly in vivo predictability. The use of a biphasic dissolution assay had a large impact on the in vitro dissolution of dipyridamole. The incorporation of an absorptive sink might be key for unraveling the supersaturation and dissolution behavior of weakly basic drug compounds.
AB - The objective of this study was to investigate the implications of changing dissolution parameters, including pH ramp time, absence and presence of simulated intestinal fluid (SIF), and the addition of a partitioning phase, using an automated dissolution-testing platform. The molar absorption coefficients, pKa, and dissolution characteristics of dipyridamole and piroxicam were investigated in the UV/Vis spectrophotometric and potentiometric platform, inForm (Pion Inc). Dissolution of dipyridamole and piroxicam from 10-mg compacts (tablets) was studied at pH 2.0 and 6.5 in fasted-state SIF version 2 (v2) and in biphasic media using decanol as the partitioning phase. Transfer through the gastrointestinal tract was simulated by shifting pH from 2.0 to 6.5 during dissolution testing. Dipyridamole (pKa 6.0) dissolved rapidly at pH 2.0; however, changing the pH to 6.5 brought dipyridamole into a supersaturated state, from which it precipitated. Precipitation was slower in the presence of SIF, and higher dipyridamole concentrations were maintained in solution compared with simple buffer systems. In the biphasic dissolution assay, rapid distribution of dipyridamole into the lipophilic partitioning phase minimized drug precipitation. For piroxicam (pKa1 1.9; pKa2 5.3), the dissolution rate increased with increasing pH. The inclusion of SIF and introduction of a partition phase had limited influence on piroxicam dissolution. The automated platform facilitated efficient exploration of dissolution conditions. Tailoring of dissolution assays including pH gradients, SIF, and biphasic partitioning enabled detailed drug characterization, increased biorelevance, and possibly in vivo predictability. The use of a biphasic dissolution assay had a large impact on the in vitro dissolution of dipyridamole. The incorporation of an absorptive sink might be key for unraveling the supersaturation and dissolution behavior of weakly basic drug compounds.
KW - Biorelevant medium
KW - biphasic dissolution
KW - dissolution
KW - InForm
KW - pH shift
KW - supersaturation
U2 - 10.14227/DT300323P144
DO - 10.14227/DT300323P144
M3 - Journal article
AN - SCOPUS:85170388675
VL - 30
SP - 144
EP - 153
JO - Dissolution Technologies
JF - Dissolution Technologies
SN - 1521-298X
IS - 3
ER -
ID: 367254716